Abstract
Advancements in immunotherapy have opened a new era in oncology, to include genetic modification of human T-cells to express a chimeric antigen receptor (CAR) that enables targeted tumor recognition (Kochenderfer et al., 2015; Lee et al., 2015; Maus and Levine 2016; Rosenberg et al., 2008). Herein, we report a false-positive HIV testing in a patient who had undergone CAR T-cell therapy created with a lentiviral vector.
Original language | English (US) |
---|---|
Pages (from-to) | 305-307 |
Number of pages | 3 |
Journal | Diagnostic Microbiology and Infectious Disease |
Volume | 88 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2017 |
Keywords
- CAR T-cell therapy
- False-positive
- HIV
- Immunotherapy
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases